The product is for medical tape applications to be used in stick-to-skin under unique climatic conditions, such as the high temperatures and humidity in the Indian sub-continent.

It delivers high tack, secure and quick bonding, under high temperature and with shear resistance. The product, which shows balancing adhesion and ease of removal, was tested and certified by ISO 10993-5 for cytotoxicity. Since it is not toxic to human cells, the adhesive can effectively be used in medical applications in hospitals and home care in stick-to-skin situations

Manish Dwivedi, flexible materials business manager for India, HB Fuller, said, “This is a breakthrough from our HB Fuller’s R&D team in India. The team has developed this technology in our lab in Pune, in response to the IMEA market specifics and to support advanced stick-to-skin products for medical use – such as medical plasters or bandages.” 

“Globally, our products have been used around the world in medical applications for more than two decades, enabling diverse new ideas and accelerating innovation for this important industry,” he added. 

The population pressure, the growing prevalence of diseases, and the increasing number of surgeries, make the global medical tapes and bandages market one that is significantly rising. This segment is expected to reach USD 8.59 billion by 2026 globally and USD 850.1 million in India, as reported on the Medical Tapes and Bandages Market – Global Forecast 2026 by MarketsandMarkets.